A committee recognized previous July by Japan’s Ministry of Well being, Labour and Welfare has been reviewing pharmaceutical rules in Japan, seeking at revisions to the prerequisites for orphan medicine, marketing the improvement of pediatric medicines and the necessity of info from Japanese members, and also the difficulty of drug shortages.